Article Details
Retrieved on: 2021-01-27 20:01:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... worth $28.6 million for the production of monoclonal antibodies (mAbs) for use in the development of a treatment and/or prophylaxis for COVID-19.
Article found on: www.genengnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here